Moreover, the CD8+ T cells were decreased in insulin-resistant groups, with an emphasis in the Pre-T2D group (27% ± 6.1) when compared to nOB (38% ± 8.6, p < 0.05), as described in Supplementary Table S2 and Figure 4E. This evidence concerns the gene CD8A and type 2 diabetes mellitus.